Clin2
NCT06542042Possibly a fitNot yet recruiting

Nanopore testing after liver transplant

Liver Transplant Infection

Part of Infections clinical trials.

This study uses a special DNA sequencing method to monitor liver transplant patients. It may help doctors detect problems earlier and improve outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
Any age
Study type
Observational

Who can take part

  • You are scheduled to receive a liver transplant
  • You are willing to sign a consent form
  • You can understand the study information
  • You have not participated in another study
  • You have not had a previous organ transplant or multi-organ transplant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06718517Recruiting
Testing drug levels to improve antibiotic therapy in liver transplant patients

This trial checks if monitoring antibiotic levels in the blood can help doctors give the right dose to liver transplant patients with serious bacterial infections. The goal is to make the treatment work better.

Bologna
NCT06212115Not yet recruiting
Infection treatment after liver transplant using mNGS testing

This trial studies whether using a special test called mNGS to find the exact infection in donated organs helps doctors choose better antibiotics for patients after a liver transplant. It may help reduce infections and improve recovery.

Shenzhen, Shenzhen
NCT06039696Recruiting
Testing a new way to find infections in liver disease patients

This trial uses a DNA test to better detect infections in people with advanced liver disease who are hospitalized. It may help doctors find the right treatment faster.

Guangzhou, Guangdong
NCT05793203Recruiting
Tests noninvasive checks to spot liver transplant complications early

This study looks at how well noninvasive tests (tests that don’t require surgery or taking tissue) can detect complications after a liver transplant. It may help patients and teams find problems earlier using safer, easier monitoring.

Rome
NCT03193151Recruiting
Microarray testing to guide care after liver transplant

This study looks at how special lab tests from tiny tissue samples (microarrays) could help guide diagnosis and treatment in people who receive a liver transplant. It may help doctors better understand what’s going on and choose care more accurately.

San Francisco, California
NCT01644903Recruiting
Checking biomarkers after a liver transplant

This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.

Chicago, Illinois

Hear when a new Liver Transplant Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.